Genes differing insignificantly from healthy tissue were IMP-3, CDH1, IQGAP1, NEDD9, TKS5, WAS and ARPC4, indicating minimal alterations in their expression levels in the analyzed cancer samples. This evidence concerns the gene SH3PXD2A and cancer.